39 results on '"San Miguel, JF"'
Search Results
2. B06: SUBCUTANEOUS TALQUETAMAB IN COMBINATION WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1B RESULTS
3. PCN140 IMPACT OF TUMOR RESPONSE ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH VELCADE/MELPHALAN/PREDNISONE (V-MP): RESULTS FROM THE VISTA TRIAL
4. Bisphosphonate‐related osteonecrosis: genetic and acquired risk factors
5. Pegylated liposomal doxorubicin, melphalan and prednisone therapy for elderly patients with multiple myeloma
6. Graft vs. Host Disease and Graft vs. Myeloma Effect after Non-myeloablative Allogeneic Transplantation
7. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation
8. Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation
9. Debate Round-Table: Comments concerning chimerism studies
10. Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation
11. Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic hybridization
12. Sequential analysis of CD34+ and CD34− cell subsets in peripheral blood and leukapheresis products from breast cancer patients mobilized with SCF plus G-CSF and cyclophosphamide
13. Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expression
14. Immunoglobulin lambda isotype gene rearrangements in B cell malignancies
15. Intra-muscular vidarabine therapy for polyomavirus-associated hemorrhagic cystitis following allogeneic hemopoietic stem cell transplantation
16. Pathologic rupture of the spleen during induction with ATRA in a patient with acute promyelocytic leukemia
17. The detection of contaminating clonal cells in apheresis products is related to response and outcome in multiple myeloma undergoing autologous peripheral blood stem cell transplantation
18. BIOMED-1 Concerted Action report: Flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL)
19. Allogeneic peripheral blood cell transplantation for hypereosinophilic syndrome with myelofibrosis
20. De novo methylation of tumor suppressor gene p16/INK4a is a frequent finding in multiple myeloma patients at diagnosis
21. Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation
22. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease
23. Factors that influence long-term hematopoietic function following autologous stem cell transplantation
24. Diagnosis of secondary myelodysplastic syndromes (MDS) following autologous transplantation should not be based only on morphological criteria used for diagnosis of de novo MDS
25. ID1 Randomised Prospective Study Comparing Cost-Effectiveness of Teicoplanin and Vancomycin As Second-Line Empiric Therapy for Infection in Neutropenic Patients
26. A new staging system for multiple myeloma based on the number of S- phase plasma cells
27. A new staging system for multiple myeloma based on the number of S- phase plasma cells
28. Serum lactate dehydrogenase level as a prognostic factor in Hodgkin's disease
29. Acute leukemia after a primary myelodysplastic syndrome: immunophenotypic, genotypic, and clinical characteristics [see comments]
30. Acute leukemia after a primary myelodysplastic syndrome: immunophenotypic, genotypic, and clinical characteristics [see comments]
31. Clinical and phenotypical characteristics of pre-T-cell leukemia [letter; comment]
32. Clinical and phenotypical characteristics of pre-T-cell leukemia [letter; comment]
33. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients
34. Leukemias with megakaryoblastic involvement: clinical, hematologic, and immunologic characteristics
35. Expression of immunologic markers in megakaryoblasts [letter]
36. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients
37. Expression of immunologic markers in megakaryoblasts [letter]
38. Prognostic factors and classification in multiple myeloma
39. Leukemias with megakaryoblastic involvement: clinical, hematologic, and immunologic characteristics
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.